European drug safety regulators are investigating whether Ozempic and other popular diabetes and weight loss medications are linked to increases in suicidal thoughts in patients.
The European Medicines Agency's drug safety panel is examining cases of suicidal and self-harm thoughts in two patients on Ozempic and one patient on a similar product, Saxenda. Both Saxenda and Ozempic are produced by Novo Nordisk, a Danish pharmaceutical company.Ozempic, which is approved by the Food and Drug Administration for treating insulin-dependent Type II diabetes, is used off-label as a weight loss medication.
The panel, which met last week, is considering whether to expand the inquiry into all GLP-1 drugs, including Ozempic, Wegovy, and Saxenda, among others. Patients who are prescribed Ozempic or Wegovy for either diabetes or weight loss often do not stay consistent with their medication, in part because GLP-1 drugs function as appetite suppressants. Although this makes them successful for their intended health effects, the patient also loses the pleasure sensation of eating.
Jens Juul Hols, a scientist instrumental in the development of GLP-1 drugs, said in an interview with Wired in June that"once you've been on this for a year or two, life is so miserably boring that you can't stand it any longer and you have to go back to your old life."Novo Nordisk told CNBC that patient safety is a"top priority" for the company and they"take all reports about adverse effects from use of [their] products very seriously.
Thoughts of self-harm are not listed as a side effect of Ozempic, but they are for Wegovy due to the results of a clinical trial for other weight loss drugs. As policy, the FDA does not comment on investigations of foreign drug regulatory bodies.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
EU probes Ozempic, weight-loss drug Saxenda after reports of suicidal thoughtsThe European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.
Leer más »
EU Investigates Ozempic Maker After Reports Of Suicidal ThoughtsThe Danish pharma giant finds itself under scrutiny once again- this time, from European regulators.
Leer más »
Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal ThoughtsEuropean drug regulators are reviewing the risk of thoughts of suicide and self-harm in people taking Ozempic and another weight-loss drug after getting three reports
Leer más »
EU Investigating Ozempic After Suicidal Thoughts ReportedDrugmaker Novo Nordisk will have its weight-loss drugs, including Ozempic, Saxenda and Wegovy, investigated after Iceland’s health regulator flagged three cases of patients reporting suicidal thoughts.
Leer más »
Ozempic diabetes and weight loss medication under investigation after a few reports of suicidal thoughtsThe popular medications Ozempic and Saxenda from Novo Nordisk are being investigated after three people experienced an increase in thoughts of suicide and self-harm.
Leer más »
Popular weight loss drug gets new warningWegovy and Ozempic are brand names for a drug called semaglutide.
Leer más »